Keywords
health care quality assurance
quality of health care
kidney diseases
How to Cite
Abstract
The clinical pathways are instruments developed to plan and coordinate the sequence of clinical and administrative procedures necessary to achieve the highest quality of care. Its rapid spread in the USA. USA explains that more than 60% of hospitals use clinical pathways for their most frequent processes. This contrasts with its poor implementation in Colombia and the countries of the Region of the Americas. The Clinical Pathways adjust with the change represented by the focus on processes, aimed at optimizing better patient care.
References
Saturno Hernández P. Cómo lograr la excelencia en la atención sanitaria. Construcción, implementación y evaluación de Vías Clínicas. Cuernavaca: Instituto Nacional de Salud Pública; 2018.
Saturno Hernández P. Métodos y herramientas para la realización de ciclos de mejora dela calidad en servicios de salud. Cuernavaca: Instituto Nacional de Salud Pública; 2015.
Ibeas J, Roca-Teyb R, Vallespínc J, Morenod T, Moñuxe G, Martí-Monrós A,et al. GuíaClínica Española del Acceso Vascular para Hemodiálisis. Nefrología. 2017;37(Suppl 1):1-192.https://dx.doi.org/10.1016/j.nefro.2017.11.004
Sou V, McManus C, Miin N, Frost SA, Ale J, Alexandrou E. A clinical pathway for themanagement of dicult venous access. BMC Nurs. 2017;16:64. https://dx.doi.org/10.1186/s12912-017-0261-z
Padilla-Galindo H, Serrano A, Polo A, García R, Acosta J, Navarro-Micr E,et al.Caracte-rización clínica-epidemiológica de las glomerulonefritis primarias un centro de referenciade caribe colombiano, en niños menores de 15 años, de enero 2008 a diciembre 2013. Rev.Colomb. Nefrol. 2014;1(Suppl 1).
Colombia. Ministerio de Salud y Protección Social (MinSalud). Guía de Práctica Clínicapara el diagnóstico y tratamiento de la Enfermedad Renal Crónica (adopción). Bogotá D.C.:MinSalud; 2016 [citado mayo 19 2021]. Disponible en: http://gpc.minsalud.gov.co/gpcsites/Repositorio/Otrosconv/GPCerenal/gpcerenal.aspx
Every NR, Hochman J, Becker R, Kopecky S, Cannon CP. Critical Pathways: a review. Com-mittee on Acute Cardiac Care, Council on Clinical Cardiology, American Heart Association.Circulation. 2000;101(4):461-5. https://dx.doi.org/10.1161/01.cir.101.4.461
Carrasco G, Ferrer J. Las vías clínicas basadas en la evidencia como estrategia para la mejo-ra de la calidad: metodología, ventajas y limitaciones. Rev. Calid. Asist. 2001;16(3):199-207.https://dx.doi.org/10.1016/S1134-282X(01)77405-2.
Zander KS, Bower KA, Etheredge MLS. Nursing Case Management: Blueprints for Trans-formation. Boston: New England Medical Center Hospitals; 1987
The National Institute for Health and Care Excellence (NICE). Kidney con-ditions overview. Londres: NICE; 2018 [citado mayo 24 2021]. Disponible en:https://pathways.nice.org.uk/pathways/kidney-conditions#content=view-node%3Anodes-autosomal-dominant-polycystic-kidney-disease.
University of Calgary. Chronic Kidney Disease Clinical Pathway. Calgary: University ofCalgary; 2020 [citado mayo 24 2021]. Disponible en: http://www.ckdpathway.ca/
Interdisciplinary Chronic Disease Collaboration & Southern Alberta Renal Program.Chronic Kidney Disease (CKD) Clinical Pathway. 2020 [citado mayo 24 2021]. Disponibleen: http://www.ckdpathway.ca/aboutthepathway
Navarro-Bermúdez M. Desarrollo e implementación de una vía clínica a los pacientes queinician la hemodiálisis de forma programada. Rev Soc Esp Enferm Nefrol. 2011;14(1):15-22
Genovese C, DE Belvis AG, Rinaldi M, Manno V, Squeri R, LA Fauci V, et al. Quality andmanagement care improvement of patients with chronic kidney disease: from data analy-sis to the denition of a targeted clinical pathway in an Italian Region. J Prev Med Hyg.2018;59(4):E305-10. https://dx.doi.org/10.15167/2421-4248/jpmh2018.59.4.999.
Colombia. Ministerio de Salud y Protección Social (MinSalud). Vía clínica para el tra-tamiento de hepatitis C crónica. Bogotá D.C.: MinSalud; 2017 [citado mayo 13 2021].Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/MET/via-clinica-tratamiento-hepatitisc.pdf
Jimenez N, Aroca-Martínez G, Santos GD. Implementación de un modelo de salud renalen red informática para la temprana detección y cuidado de la nefropatía primaria lúpicay glomerulonefritis en la Región Caribe Colombiana. Rev. Colomb. Nefrol. 2014;1(Suppl 1).
Castillo-Parodi L, Navarro-Jiménez E, Arango-Quiroz Y, López-Avendaño A, Mejía-VarelaV, González-Torres HJ,et al. Obesity Association with Chronic Renal Disease in Patientsattended at Clínica de la Costa. Barranquilla, Colombia. 2005-2014. Rev. Colomb. Nefrol.2021;3(1):14-9. https://doi.org/10.22265/acnef.3.1.217
Genovese C, DE Belvis AG, Rinaldi M, Manno V, Squeri R, LA Fauci V,et al.Quality andmanagement care improvement of patients with chronic kidney disease: from data analy-sis to the denition of a targeted clinical pathway in an Italian Region. J Prev Med Hyg.2018;59(4):E305-10. https://dx.doi.org/10.15167/2421-4248/jpmh2018.59.4.999
Childrens Hospital Colorado. Venous thromboembolism (VTE) prevention. Clinical pathway; 2020 [citado mayo 24 de 2021]. Disponible en: https://www.childrenscolorado.org/4adc94/globalassets/healthcare-professionals/clinical-pathways/venous-thromboembolism.pdf
Canadá. Ministry of Health and Long-Term Care. Quality-Based Procedures ClinicalHandbook for Chronic Kidney Disease Ontario: Ministry of Health and Long-Term Care;2016 [citado mayo 24 2021]. Disponible en: http://www.health.gov.on.ca/en/pro/programs/ecfa/docs/qbpkidney.pdf
Curtis C, Balint C, Al Hamarneh YN, Donald M, Tsuyuki RT, McBrien K,et al. Onli-ne clinical pathway for managing adults with chronic kidney disease. Can Pharm J (Ott).2015;148(5):257-62. https://doi.org/10.1177/1715163515597243.
Donald M, McBrien K, Jackson W, Manns BJ, Tonelli M, King-Shier K,et al. Develop-ment and implementation of an online clinical pathway for adult chronic kidney disea-se in primary care: a mixed methods study. BMC Med Inform Decis Mak. 2016;16:109.https://doi.org/10.1186/s12911-016-0350-z
Gruber-Baldini AL, Velozo C, Romero S, Shulman LM. Validation of the PROMIS®mea-sures of self-ecacy for managing chronic conditions. Qual. Life Res. 2017;26(7):1915-24.https://doi.org/10.1007/s11136-017-1527-3.
Johnson ML, Zimmerman L, Welch JL, Hertzog M, Pozehl B, Plumb T. Patient activationwith knowledge, self-management and condence in chronic kidney disease. J Ren Care.2016;42(1):15-22. https://doi.org/10.1111/jorc.12142.
Ploeg J, Matthew-Maich N, Fraser K, Dufour S, McAiney C, Kaasalainen S,et al. Managingmultiple chronic conditions in the community: a Canadianqualitative study of the experien-ces of older adults, family caregivers and healthcare providers. BMC Geriatr. 2017;17(1):40.https://doi.org/10.1186/s12877-017-0431-6.
Dobkowski D, Zuber K, Davis J. Updated guidelines for managing chronic kidney disease.JAAPA. 2013;26(11):27-31. https://doi.org/10.1097/01.JAA.0000436686.98552.56.
Post FA. Managing chronic kidney disease in the older adults living with HIV. Curr OpinInfect Dis. 2017;30(1):4-11. https://doi.org/10.1097/QCO.0000000000000333.
Coyne E, Langham H, Tomlin M, Hope W, Johnson C, Byrne C,et al. Young adults withchronic kidney disease: An exploration of their relationships and support networks. J RenCare. 2019;45(1):20-8. https://doi.org/10.1111/jorc.12263.
Toy JM, Drechsler A, Waters RC. Clinical pathways for primary care: current use, interestand perceived usability. J Am Med Inform Assoc. 2018;25(7):901-6. https://doi.org/10.1093/jamia/ocy010
Grimsmo A, Løhre A, Røsstad T, Gjerde I, Heiberg I, Steinsbekk A. Disease- specic cli-nical pathways - are they feasible in primary care? A mixed-methods study. Scand J PrimHealth Care. 2018;36(2):152-60. https://doi.org/10.1080/02813432.2018.1459167.
Mejia C, Libby BA, Bracken ML, Shanley B, Holovatska MM, Wanik J,et al.Interest inDigital Dietary Support Among Adults With Kidney Failure Receiving Hemodialysis. J RenNutr. 2020;31(3):327-32. https://doi.org/10.1053/j.jrn.2020.06.004.
Harwood L, Clark AM. Dialysis modality decision-making for older adults with chronickidney disease. J Clin Nurs. 2014;23(23-24):3378-90. https://doi.org/10.1111/jocn.12582.
Tam-Tham H, Hemmelgarn BR, Campbell DJ, Thomas CM, Fruetel K, Quinn RR,et al. Pri-mary care physicians’ perceived barriers, facilitators and strategies to enhance conservativecare for older adults with chronic kidney disease: a qualitative descriptive study. NephrolDial Transplant. 2016;31(11):1864-70. https://doi.org/10.1093/ndt/gfv408.
Tahir M, Hassan S, de Lusignan S, Shaheen L, Chan T, Dmitrieva O. Developmentof a questionnaire to evaluate practitioners’ condence and knowledge in primary ca-re in managing chronic kidney disease. BMC Nephrol. 2014;15:73. https://doi.org/10.1186/1471-2369-15-73.
Owen JE, Walker RJ, Edgell L, Collie J, Douglas L, Hewitson TD,et al. Implementationof a pre-dialysis clinical pathway for patients with chronic kidney disease. Int J Qual HealCare. 2006;18(2):145-51. https://doi.org/10.1093/intqhc/mzi094
Tsuyuki RT. Rearming our focus on patient-centred care. Can Pharm J (Ott).2015;148(5):225-6. https://doi.org/10.1177/1715163515599963.
Smekal MD, Tam-Tham H, Finlay J, Donald M, Benterud E, Thomas C,et al. Perceived Be-nets and Challenges of a Risk-Based Approach to Multidisciplinary Chronic Kidney Disea-se Care: A Qualitative Descriptive Study. Can J Kidney Health Dis. 2018;5:205435811876380.https://doi.org/10.1177/2054358118763809.
Geense WW, van Gaal BG, Knoll JL, Cornelissen EA, Schoonhoven L, Kok G. OnlineSupport Program for Parents of Children With a Chronic Kidney Disease Using InterventionMapping: A Development and Evaluation Protocol. JMIR Res. Protoc. 2016;5(1):e1. https://doi.org/10.2196/resprot.4837
Kasiske B, Cosio FG, Beto J, Bolton K, Chavers BM, Grimm R Jr,et al. Clinical practiceguidelines for managing dyslipidemias in kidney transplant patients: a report from the Ma-naging Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foun-dation Kidney Disease Outcomes Quality Initiative. Am J Transplant. 2004;4(Suppl 7):13-53.https://doi.org/10.1111/j.1600-6135.2004.0355.x.
Lovre D., Shah S, Sihota A, Fonseca VA. Managing Diabetes and Cardiovascular Riskin Chronic Kidney Disease Patients. Endocrinol Metab Clin North Am. 2018;47(1):237-57.https://doi.org/10.1016/j.ecl.2017.10.006
Zac-Varghese S, Winocour P. Managing diabetic kidney disease. Br Med Bull.2018;125(1):55-66. https://doi.org/10.1093/bmb/ldx047
Clemens KK, O’Regan N, Rhee JJ. Diabetes Management in Older Adults With Chro-nic Kidney Disease. Curr Diab Rep. 2019;19(3):11. https://doi.org/10.1007/s11892-019-1128-3
Lo C, Zimbudzi E, Teede H, Cass A, Fulcher G, Gallagher M,et al. Models of care for co-morbid diabetes and chronic kidney disease. Nephrology (Carlton). 2018;23(8):711-7. https://doi.org/10.1111/nep.13232
Fitzpatrick A, Mohammadi F, Jesudason S. Managing pregnancy in chronic kidney di-sease: improving outcomes for mother and baby. Int J Womens Health. 2016;8:273-85.https://doi.org/10.2147/IJWH.S76819
Wiles K, Chappell L, Clark K, Elman L, Hall M, Lightstone L,et al.Clinical practice guide-line on pregnancy and renal disease. BMC Nephrol. 2019;20(1):401. https://doi.org/10.1186/s12882-019-1560-2
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.